A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
RET FISH analysis is a sensitive but highly unspecific screening method for RET fusions in lung cancer
2021
Journal of Thoracic Oncology
RET gene fusions are established oncogenic drivers in 1% of non-small cell lung cancer (NSCLC). Accurate detection of advanced patients with RET fusions is essential to ensure optimal therapy choice. We investigated performance of fluorescence in situ hybridization (FISH) as diagnostic test for detecting functional RET fusions. Between January 2016 and November 2019, 4873 NSCLC patients were routinely screened for RET fusions using either FISH (n=2858) or targeted RNA next generation sequencing
doi:10.1016/j.jtho.2021.01.1619
pmid:33588111
fatcat:n5yy5e63gzedpamawssbktc2uu